For example, it has been demonstrated that miR-4443 promotes the metastatic properties of breast cancer and esophageal squamous cell carcinoma by suppressing the tissue inhibitors of metalloproteinase 2 (TIMP2) [47–50]. This evidence concerns the gene TIMP2 and esophageal squamous cell carcinoma.